Peter Anevski Biography and Net Worth

COO of Progyny


Peter Anevski currently serves as the president and chief operating officer of Progyny Inc. 

Anevski first joined Progyny in 2017 as the company’s executive vice president, COO and chief financial officer, becoming president and COO in September 2020. During his time at Progyny, Anesvski has headed the company’s financial actions, optimized its operations and built up its premier provider network. 

Prior to joining Progyny, Anevski spent over 17 years as the executive vice president and CFO of WebMD, beginning in 1999. During his tenure, Anevski played a major role in improving WebMD’s financial performance. From 1994 to 1999, Anevski worked in corporate accounting for Toys “R” Us. He began his career as a public auditor and CPA with Wiss & Company in 1992. 

Anevski earned his undergraduate degree from Montclair State University and is a member at The American Institute of Certified Public Accountants and the New Jersey State Society of Certified Public Accountants.

What is Peter Anevski's net worth?

The estimated net worth of Peter Anevski is at least $6.87 million as of July 13th, 2023. Mr. Anevski owns 207,947 shares of Progyny stock worth more than $6,874,728 as of May 7th. This net worth estimate does not reflect any other investments that Mr. Anevski may own. Additionally, Mr. Anevski receives an annual salary of $1,090,000.00 as COO at Progyny. Learn More about Peter Anevski's net worth.

How old is Peter Anevski?

Mr. Anevski is currently 57 years old. There are 4 older executives and no younger executives at Progyny. Learn More on Peter Anevski's age.

What is Peter Anevski's salary?

As the COO of Progyny, Inc., Mr. Anevski earns $1,090,000.00 per year. Learn More on Peter Anevski's salary.

How do I contact Peter Anevski?

The corporate mailing address for Mr. Anevski and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Peter Anevski's contact information.

Has Peter Anevski been buying or selling shares of Progyny?

Peter Anevski has not been actively trading shares of Progyny during the last ninety days. Most recently, Peter Anevski sold 32,000 shares of the business's stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $38.94, for a transaction totalling $1,246,080.00. Following the completion of the sale, the chief executive officer now directly owns 207,947 shares of the company's stock, valued at $8,097,456.18. Learn More on Peter Anevski's trading history.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.

Are insiders buying or selling shares of Progyny?

In the last twelve months, insiders at the sold shares 37 times. They sold a total of 3,776,446 shares worth more than $152,024,990.14. The most recent insider tranaction occured on May, 1st when President Michael E Sturmer sold 4,515 shares worth more than $144,254.25. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.

Information on this page was last updated on 5/1/2024.

Peter Anevski Insider Trading History at Progyny

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/13/2023Sell32,000$38.94$1,246,080.00207,947View SEC Filing Icon  
7/3/2023Sell6,439$38.78$249,704.42215,924View SEC Filing Icon  
6/7/2023Sell16,000$40.97$655,520.00215,924View SEC Filing Icon  
6/5/2023Sell16,000$40.00$640,000.00215,924View SEC Filing Icon  
6/2/2023Sell16,000$38.67$618,720.00215,924View SEC Filing Icon  
5/15/2023Sell32,000$36.24$1,159,680.00215,924View SEC Filing Icon  
5/12/2023Sell32,000$36.30$1,161,600.00215,924View SEC Filing Icon  
5/10/2023Sell32,000$37.74$1,207,680.00215,924View SEC Filing Icon  
5/8/2023Sell22,932$35.09$804,683.88215,924View SEC Filing Icon  
4/24/2023Sell1,857$35.00$64,995.00215,924View SEC Filing Icon  
4/21/2023Sell8,370$35.01$293,033.70215,924View SEC Filing Icon  
3/2/2023Sell32,000$36.12$1,155,840.00223,901View SEC Filing Icon  
2/6/2023Sell2,305$35.28$81,320.40223,900View SEC Filing Icon  
2/2/2023Sell32,000$36.37$1,163,840.00223,900View SEC Filing Icon  
1/31/2023Sell735$35.00$25,725.00223,093View SEC Filing Icon  
11/3/2022Sell3,920$39.19$153,624.80250,445View SEC Filing Icon  
10/25/2022Sell34,385$39.76$1,367,147.60250,445View SEC Filing Icon  
10/20/2022Sell2,248$39.38$88,526.24250,445View SEC Filing Icon  
10/17/2022Sell400$39.33$15,732.00250,445View SEC Filing Icon  
10/14/2022Sell2,160$39.41$85,125.60250,445View SEC Filing Icon  
10/6/2022Sell19,602$40.24$788,784.48250,445View SEC Filing Icon  
9/8/2022Sell32,000$41.61$1,331,520.00324,916View SEC Filing Icon  
8/11/2022Sell16,000$44.68$714,880.00324,916View SEC Filing Icon  
8/9/2022Sell16,000$41.64$666,240.00324,916View SEC Filing Icon  
6/27/2022Sell80$31.21$2,496.80324,916View SEC Filing Icon  
3/4/2022Sell21,000$43.59$915,390.00View SEC Filing Icon  
3/2/2022Sell21,000$44.02$924,420.00View SEC Filing Icon  
2/28/2022Sell125,931$39.09$4,922,642.79View SEC Filing Icon  
2/15/2022Sell17,569$41.39$727,180.91View SEC Filing Icon  
2/11/2022Sell600$42.00$25,200.00View SEC Filing Icon  
1/3/2022Sell21,000$51.17$1,074,570.00View SEC Filing Icon  
10/7/2021Sell27,539$59.53$1,639,396.67View SEC Filing Icon  
10/5/2021Sell27,500$57.98$1,594,450.00View SEC Filing Icon  
9/30/2021Sell88,882$56.72$5,041,387.04View SEC Filing Icon  
9/28/2021Sell55,000$56.86$3,127,300.00View SEC Filing Icon  
8/25/2021Sell63,621$51.74$3,291,750.54View SEC Filing Icon  
6/3/2021Sell21,000$62.49$1,312,290.00499,079View SEC Filing Icon  
6/1/2021Sell21,000$63.99$1,343,790.00499,079View SEC Filing Icon  
5/5/2021Sell21,000$53.21$1,117,410.00583,079View SEC Filing Icon  
5/3/2021Sell21,000$56.18$1,179,780.00583,079View SEC Filing Icon  
4/7/2021Sell200$45.74$9,148.00667,079View SEC Filing Icon  
4/5/2021Sell26,833$46.08$1,236,464.64667,079View SEC Filing Icon  
4/1/2021Sell800$46.19$36,952.00667,079View SEC Filing Icon  
3/10/2021Sell8,999$47.43$426,822.57667,079View SEC Filing Icon  
2/3/2021Sell21,000$47.84$1,004,640.00666,146View SEC Filing Icon  
2/1/2021Sell21,000$47.93$1,006,530.00666,146View SEC Filing Icon  
1/6/2021Sell21,000$43.30$909,300.00666,146View SEC Filing Icon  
1/4/2021Sell21,000$42.47$891,870.00666,146View SEC Filing Icon  
12/3/2020Sell21,000$37.12$779,520.00834,146View SEC Filing Icon  
12/1/2020Sell21,000$35.50$745,500.00834,146View SEC Filing Icon  
11/13/2020Sell12,886$30.95$398,821.70834,146View SEC Filing Icon  
11/11/2020Sell97,503$29.79$2,904,614.37834,146View SEC Filing Icon  
11/9/2020Sell37,454$29.88$1,119,125.52834,146View SEC Filing Icon  
9/29/2020Sell84,000$29.30$2,461,200.00834,146View SEC Filing Icon  
8/28/2020Sell80,000$28.61$2,288,800.00918,146View SEC Filing Icon  
8/17/2020Sell35,000$29.96$1,048,600.001,453,146View SEC Filing Icon  
8/14/2020Sell75,000$29.55$2,216,250.001,453,146View SEC Filing Icon  
8/12/2020Sell11,378$30.06$342,022.681,564,755View SEC Filing Icon  
7/13/2020Sell24,940$27.74$691,835.601,470,579View SEC Filing Icon  
7/10/2020Sell4,444$27.70$123,098.801,470,579View SEC Filing Icon  
5/13/2020Sell84,000$25.06$2,105,040.001,550,135View SEC Filing Icon  
10/29/2019Sell20,000$45.20$904,000.00
See Full Table

Peter Anevski Buying and Selling Activity at Progyny

This chart shows Peter Anevski's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $33.06
Low: $32.20
High: $33.84

50 Day Range

MA: $34.95
Low: $31.72
High: $40.79

2 Week Range

Now: $33.06
Low: $29.44
High: $44.95

Volume

1,344,473 shs

Average Volume

787,787 shs

Market Capitalization

$3.18 billion

P/E Ratio

53.32

Dividend Yield

N/A

Beta

1.51